Our in vivo tests in mouse models showed that treatment using an inhibitor of VEGFR-2 (an important receptor of VEGFA) or an inhibitor of eNOS reduced the severity of infection and tissue damage caused by P. multocida infection, while treatment with an agonist of HIF-1α increased infection and damage (Fig. 5). Here, NOS3 is linked to infection.